Abstract:The aim of this study is to evaluate the diagnostic value of genome sequencing in children with epilepsy, and to provide genome sequencing-based insights into the molecular genetic mechanisms of epilepsy to help establish accurate diagnoses, design appropriate treatments and assist in genetic counselling. We performed genome sequencing on 320 Chinese children with epilepsy, and interpreted single-nucleotide variants and copy number variants of all samples. The complete pedigree and clinical data of the probands were established and followed up. The clinical phenotypes, treatments, prognoses and genotypes of the patients were analysed. Age at seizure onset ranged from 1 day to 17 years, with a median of 4.3 years. Pathogenic/likely pathogenic variants were found in 117 of the 320 children (36.6%), of whom 93 (29.1%) had single-nucleotide variants, 22 (6.9%) had copy number variants and two had both single-nucleotide variants and copy number variants. Single-nucleotide variants were most frequently found in SCN1A (10/95, 10.5%), which is associated with Dravet syndrome, followed by PRRT2 (8/95, 8.4%), which is associated with benign familial infantile epilepsy, and TSC2 (7/95, 7.4%), which is associated with tuberous sclerosis. Among the copy number variants, there were three with a length 525 kilobases. The most common recurrent copy number variants were 17p13.3 deletions (5/24, 20.8%), 16p11.2 deletions (4/24, 16.7%), and 7q11.23 duplications (2/24, 8.3%), which are associated with epilepsy, developmental retardation and congenital abnormalities. Four particular 16p11.2 deletions and two 15q11.2 deletions were considered to be susceptibility factors contributing to neurodevelopmental disorders associated with epilepsy. The diagnostic yield was 75.0% in patients with seizure onset during the first postnatal month, and gradually decreased in patients with seizure onset at a later age. Forty-two patients (13.1%) were found to be specifically treatable for the underlying genetic cause identified by genome sequencing. Three of them received corresponding targeted therapies and demonstrated favourable prognoses. Genome sequencing provides complete genetic diagnosis, thus enabling individualized treatment and genetic counselling for the parents of the patients. Genome sequencing is expected to become the first choice of methods for genetic testing of patients with epilepsy.

Exome sequencing in a Chinese cohort of children with cerebral palsy identifies likely pathogenic variants

Exome sequencing reveals genetic heterogeneity and clinically actionable findings in children with cerebral palsy

Genetic Spectrum Identified by Exome Sequencing in a Chinese Pediatric Cerebral Palsy Cohort

Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy

Exome-wide Association Study Identified Genetic Variants Contributing to the Risk of Cerebral Palsy

In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy

Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy

Mutations Disrupting Neuritogenesis Genes Confer Risk for Cerebral Palsy.

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing

Genetic Diagnosis Spectrum and Multigenic Burden of Exome-Level Rare Variants in a Childhood Epilepsy Cohort

Clinical and Genetic Spectrum of a Large Cohort of Children with Epilepsy in China

Genetic investigations in cerebral palsy

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

The Genetic Puzzle of Cerebral Palsy: Results of a Monocentric Study

[Genetic and clinical analysis of two children with microcephaly and mental retardation due to a frameshifting variant of CASK gene]

Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study

Genetic Variants in the HLA Region Contribute to the Risk of Cerebral Palsy.

Genotype and Phenotype Analysis Using an Epilepsy‐associated Gene Panel in Chinese Pediatric Epilepsy Patients

Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy

Analysis copy number variation of Chinese children in early-onset epileptic encephalopathies with unknown cause.